
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
Akimichi Inaba, Zewen Kelvin Tuong, Tian Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Akimichi Inaba, Zewen Kelvin Tuong, Tian Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Showing 22 citing articles:
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics
Miro E. Raeber, Dominic Caspar, Yves Zurbuchen, et al.
Immunity (2024) Vol. 57, Iss. 9, pp. 2232-2250.e10
Open Access | Times Cited: 9
Miro E. Raeber, Dominic Caspar, Yves Zurbuchen, et al.
Immunity (2024) Vol. 57, Iss. 9, pp. 2232-2250.e10
Open Access | Times Cited: 9
An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases
Hale Radi, Elaheh Ferdosi-Shahandashti, Gholam Ali Kardar, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 4, pp. 143-157
Closed Access | Times Cited: 5
Hale Radi, Elaheh Ferdosi-Shahandashti, Gholam Ali Kardar, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 4, pp. 143-157
Closed Access | Times Cited: 5
Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease
James W. O’Brien, Ayden Case, Claudia Kemper, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1512-1522
Open Access | Times Cited: 5
James W. O’Brien, Ayden Case, Claudia Kemper, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1512-1522
Open Access | Times Cited: 5
T-Cell/B-Cell Interactions in Atherosclerosis
Peter William Jones, Ziad Mallat, Meritxell Nus
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1502-1511
Open Access | Times Cited: 4
Peter William Jones, Ziad Mallat, Meritxell Nus
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1502-1511
Open Access | Times Cited: 4
Genetic insights into the relationship between immune cell traits and abnormal uterine bleeding: A Mendelian randomization study
Wen‐Ting Ou, Pan Du, Xian–Xu Bai, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41609-e41609
Open Access
Wen‐Ting Ou, Pan Du, Xian–Xu Bai, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41609-e41609
Open Access
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease
Rukshan A. M. Rafeek, Natkunam Ketheesan, Michael F. Good, et al.
mBio (2025)
Open Access
Rukshan A. M. Rafeek, Natkunam Ketheesan, Michael F. Good, et al.
mBio (2025)
Open Access
IL-2Rα is dispensable for murine B cell development and humoral response
Priyanka Chowdhury, Kalina T. Belcheva, Ryan Smolkin, et al.
The Journal of Immunology (2025) Vol. 214, Iss. 4, pp. 694-702
Closed Access
Priyanka Chowdhury, Kalina T. Belcheva, Ryan Smolkin, et al.
The Journal of Immunology (2025) Vol. 214, Iss. 4, pp. 694-702
Closed Access
Role of IRF4 in mediating plasmablast differentiation in diffuse large B-cell lymphomas via mTORC1 pathway
Jingjing Gao, Chuntuan Li, Xingzhi Lin, et al.
Annals of Hematology (2025)
Open Access
Jingjing Gao, Chuntuan Li, Xingzhi Lin, et al.
Annals of Hematology (2025)
Open Access
Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model
Rui Su, Hui Wang, Baochen Li, et al.
Clinical Rheumatology (2025)
Closed Access
Rui Su, Hui Wang, Baochen Li, et al.
Clinical Rheumatology (2025)
Closed Access
Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus
Enikő Szabó, Anna F. Farago, Gergely Bodor, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Enikő Szabó, Anna F. Farago, Gergely Bodor, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study
Nisat Sarmin, A. S. M. Roknuzzaman, Rapty Sarker, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Nisat Sarmin, A. S. M. Roknuzzaman, Rapty Sarker, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
A causal relationship between distinct immune features and acute or chronic pancreatitis: results from a mendelian randomization analysis
Ru‐Juan Liu, Kui Wang, Xiaoyu Guo, et al.
Pancreatology (2024)
Closed Access | Times Cited: 3
Ru‐Juan Liu, Kui Wang, Xiaoyu Guo, et al.
Pancreatology (2024)
Closed Access | Times Cited: 3
B Cell–mediated Immune Regulation and the Quest for Transplantation Tolerance
Laurie Baert, Hasan Md Mahmudul, Mark D. Stegall, et al.
Transplantation (2024) Vol. 108, Iss. 10, pp. 2021-2033
Closed Access | Times Cited: 1
Laurie Baert, Hasan Md Mahmudul, Mark D. Stegall, et al.
Transplantation (2024) Vol. 108, Iss. 10, pp. 2021-2033
Closed Access | Times Cited: 1
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes
Zhengkang Luo, Mariela Mejia‐Cordova, Nour Hamze, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 626-637
Open Access | Times Cited: 1
Zhengkang Luo, Mariela Mejia‐Cordova, Nour Hamze, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 626-637
Open Access | Times Cited: 1
In vitro modulation of T cells in myasthenia gravis by low‐dose IL‐2
Merve Çebi, Arman Çakar, Hacer Durmuş, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 1
Merve Çebi, Arman Çakar, Hacer Durmuş, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 11
Closed Access | Times Cited: 1
Metabolic impact of low dose IL-2 therapy for primary Sjögren’s Syndrome in a double-blind, randomized clinical trial
Ruiling Feng, Xian Xiao, Yifan Wang, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 12, pp. 3789-3798
Open Access | Times Cited: 1
Ruiling Feng, Xian Xiao, Yifan Wang, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 12, pp. 3789-3798
Open Access | Times Cited: 1
Expansion of B10 cells in vitro: Pathways, techniques and applications in transplantation (Review)
Dayue Zhao, Guoli Huai, Yuan Yuan, et al.
International Journal of Molecular Medicine (2024) Vol. 55, Iss. 2
Closed Access | Times Cited: 1
Dayue Zhao, Guoli Huai, Yuan Yuan, et al.
International Journal of Molecular Medicine (2024) Vol. 55, Iss. 2
Closed Access | Times Cited: 1
Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
Zhengkang Luo, Mariela Mejia‐Cordova, Nour Hamze, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Zhengkang Luo, Mariela Mejia‐Cordova, Nour Hamze, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024
Al Nasar Ahmed Sehgal, Peter A. Tauber, Robert B. Stieger, et al.
International Archives of Allergy and Immunology (2023) Vol. 185, Iss. 3, pp. 286-300
Open Access | Times Cited: 2
Al Nasar Ahmed Sehgal, Peter A. Tauber, Robert B. Stieger, et al.
International Archives of Allergy and Immunology (2023) Vol. 185, Iss. 3, pp. 286-300
Open Access | Times Cited: 2
34-parameter full spectrum immunophenotyping panel of human regulatory and effector lymphocytes
Zoya Georgieva, Valerie Coppard, Jennie H. M. Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zoya Georgieva, Valerie Coppard, Jennie H. M. Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Regulatory B Cells Expressing Granzyme B from Tolerant Renal Transplant Patients: Highly Differentiated B Cells with a Unique Pathway with a Specific Regulatory Profile and Strong Interactions with Immune System Cells
Nicolas Sailliet, Amandine Dupuy, François Brinas, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1287-1287
Open Access
Nicolas Sailliet, Amandine Dupuy, François Brinas, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1287-1287
Open Access
Immunotherapeutic strategy to prevent progression and complications of acute rheumatic fever
Rukshan A. M. Rafeek, Natkunam Ketheesan, Michael F. Good, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rukshan A. M. Rafeek, Natkunam Ketheesan, Michael F. Good, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterization of class-switched B cells in chickens
Dominik von La Roche, Magdalena Schumacher, Marina Kohn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Dominik von La Roche, Magdalena Schumacher, Marina Kohn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Atherosclerosis antigens as targets for immunotherapy
Irene Raposo-Gutiérrez, Ana Rodríguez-Ronchel, Almudena R. Ramiro
Nature Cardiovascular Research (2023) Vol. 2, Iss. 12, pp. 1129-1147
Closed Access | Times Cited: 1
Irene Raposo-Gutiérrez, Ana Rodríguez-Ronchel, Almudena R. Ramiro
Nature Cardiovascular Research (2023) Vol. 2, Iss. 12, pp. 1129-1147
Closed Access | Times Cited: 1